Adhesion Barrier Market (2023 - 2030)

Adhesion Barrier Market Summary

The global adhesion barrier market size was valued at USD 859.95 million in 2022 and is projected to reach USD 1.50 billion by 2030, growing at a CAGR of 7.3% from 2023 to 2030. The key drivers of the market are the rising geriatric population coupled with the increasing number of surgical procedures.

The surging frequency of invasive surgeries with a high risk of postoperative complications is anticipated to trigger market growth. However, with the rising risk of post-operation adhesion, the market is still witnessing barrier in terms of accessibility, lack of health education, and lack of awareness about the importance of treatment.

The adhesion barrier market is expected to see significant growth due to a few key factors. The improvement in healthcare infrastructure and the increasing availability of trauma care centers will drive the market forward. Additionally, the growing incidence of sports-related injuries is also expected to contribute to the growth of the market. Recent data from Stanford Children's Health shows that out of the approximately 30 million children who participate in some form of sports, over 10% experience injuries each year.

Also, the British Heart Foundation estimates that 32,938 completed heart surgeries and other heart procedures were carried out in England in just the month of October 2021. The rising frequency of operations and surgeries is anticipated to increase demand for adhesion barrier, further boosting market expansion. Adhesion barrier are frequently used after surgeries to lessen scars and avoid adhesions.

The adhesion barrier market is seeing growth due to several factors. Rising healthcare expenditure, along with increased FDA approval for various adhesion barrier products, is contributing to the market's expansion. For instance, Ethicon, Inc., a subsidiary of Johnson & Johnson, received FDA clearance for its VISTASEAL Fibrin Sealant (Human) product in November 2020. This product is designed to be used as an adjunct to hemostasis during surgery, to reduce the incidence of postoperative adhesions.

The FDA's approval of this product is just one example of how innovation and advancements in medical technology are driving growth in the advanced adhesion barrier market. As companies continue to develop new and improved products that can help prevent postoperative adhesions, we can expect to see increased demand for these products.

Product Insights

The Synthetic adhesion barrier accounted for the largest market size owing to high bioresorbable and biocompatibility. Synthetic adhesion barriers are cost-effective which is expected to increase sales of the segment. Moreover, the dominance of the segment is primarily attributed to the availability of commercial synthetic adhesion barrier. The segment is further divided into hyaluronic acid, regenerated cellulose, polyethylene glycol, and others. The hyaluronic acid segment dominates, owing to its capacity to attract and hold a vast amount of moisture.

Natural adhesion barrier segment also accounted for a considerable market share in 2022 and is expected to grow at a lucrative rate during the forecast period. The segment is further divided into collagen & protein, and fibrin. Collagen & protein segment held the largest market size owing to its benefits such as durability and safety. The fibrin segment is expected to grow at a rapid pace during the forecast period. The high growth rate of the fibrin segment is primarily attributed to the rising adoption of these products

Formulation Insights

The film/mesh segment dominated the market and accounted for the largest market share in 2022 and is expected to maintain its dominance during the forecast period. The large share of the segment is primarily attributed to its low cost and increasing use of film form adhesion in various surgeries. In addition, many clinical evidence are supporting the efficiency and safety of these forms of adhesion, thus, adding growth to the market growth.

Gel is expected to grow at the fastest rate during the forecast period. The high growth rate of the segment is primarily attributed to its advantages such as affordability, resorbability, easy application, and safety. Moreover, increasing usage of gels in various surgeries such as tendon, carpal tunnel, and joint or peripheral surgery is expected to expand its applications in upcoming years.

Application Insights

The cardiovascular surgeries segment dominated the market and is expected to grow at the fastest CAGR during the forecast period. The rising incidence of heart-related diseases and the increasing use of adhesion barrier in cardiovascular surgeries are the main drivers of growth in this segment of the advanced adhesion barrier market. A recent study published in the Annals of Medicine and Surgery in 2020 found that adhesion barriers are also beneficial in preventing the formation of peristomal adhesion. This highlights the versatility of adhesion barrier and their potential to improve patient outcomes in a variety of surgical procedures.

Gynecological surgery segment held the largest market share in 2022 and is expected to maintain its dominance during the forecast period. Market dominance is primarily attributed to a rising number of gynecologic laparoscopy procedures. Furthermore, increasing the adoption of gel form and film form in various gynecological procedures including endometriosis surgery, ovarian cystectomy, and ectopic pregnancy are boosting the market growth. Slow adoption of minimally invasive techniques in developing countries is expected to have a positive impact on the adoption of adhesion barrier. Minimally invasive surgeries require high priced equipment such as cameras and robot-assisted devices. Adoption of these devices is expected to be moderate in developing countries because of price sensitive customers.

Regional Insights

North America region dominated the adhesion barrier market and accounted for the largest revenue share in 2022. The market owing to the presence of major players such as Johnson & Johnson, Baxter International, Integra LifeSciences, Anika Therapeutics, and FzioMed. Increase in the prevalence of orthopedic conditions coupled with the high adoption of advanced treatment procedures is anticipated to fuel the market growth in the U.S.

Asia Pacific adhesive barrier market is expected to grow at a lucrative rate over the forecast period. The high growth rate in the region is primarily attributed to the rising geriatric population and increasing incidence of cardiac and neurosurgery which require surgical interventions. Moreover, rising private sector investment in healthcare and rapidly expanding medical tourism are expected to drive the growth of the adhesion barrier market in the region. Major countries such as India, China, and Japan are expected to contribute maximum growth to the region during the forecast period.

Adhesion Barrier Market Share Insights

To maintain market share, many players in the advanced adhesion barrier market are adopting strategies such as increasing product launches, mergers & acquisitions, partnerships, and technological collaborations. For instance, In 2022 Gunze announced the launch of the TENALEAF absorbable adhesion barrier in Japan. This strategic move is helping the company to expand its product portfolios and improve its market presence, which is essential in this highly competitive market. Some of the key players in the global adhesion barrier market include:

• Sanofi S.A.

• Becton Dickinson and Company

• Baxter International, Inc.

• Johnson & Johnson

• Anika Therapeutic, Inc.

• FzioMed, Inc,

• Mast Biosurgery, Inc.,

• Innocoll Holdings PLC

• Atrium Medical Corporation (A part of Getinge Group).

Adhesion Barrier Market